Antares Pharma reported $7.71M in EBITDA for its second fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Ebitda Change
Abbott ABT:US $ 3042M 769M
Adamas Pharmaceuticals ADMS:US -5502000 3.51M
Adma Biologics ADMA:US $ -13.02M 1.24M
Aerie Pharmaceuticals AERI:US $ -30.76M 0.92M
Ani Pharmaceuticals ANIP:US $ 8.01M 3.32M
Atrion ATRI:US 12.8M 117K
Becton, Dickinson and BDX:US $ 1368M 274M
Cerus CERS:US $ -10.36M 3.26M
Eli Lilly And LLY:US $ 2437.5M 639.8M
Endo International Ordinary Shares ENDP:US $ 320.03M 5.28M
Horizon Pharma HZNP:US $ 439.93M 134.24M
JAZZ PHA JAZZ:US $ 195.95M 118.22M
Pacira Pharmaceuticals PCRX:US $ 36.49M 3.4M
Pfizer PFE:US $ 10235M 2245M
Revance Therapeutics RVNC:US $ -67.57M 2.28M
Sientra SIEN:US $ -10.66M 2.22M
Staar Surgical STAA:US $ 8.76M 2.78M
Supernus Pharmaceuticals SUPN:US $ 38.61M 2.15M
Teva Pharmaceutical TEVA:IT 1.14B 1000K
Teva Pharmaceutical Industries TEVA:US $ 1137M 1M
Zogenix ZGNX:US $ -51.9M 1.17M